Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2022-04-04 Sale | 2022-04-05 5:40 pm | Equillium Inc. | EQ | Keyes Jason A CFO | 8,000 | $3.18 | $25,440 | 113,016 (Indirect Direct) | View |
2021-12-01 Sale | 2021-12-03 1:57 pm | Equillium Inc. | EQ | Keyes Jason A CFO | 5,000 | $5.0803 | $25,402 | 115,431 (Indirect Direct) | View |
2021-11-16 Sale | 2021-11-17 3:27 pm | Equillium Inc. | EQ | Zedelmayer Christine COO | 11,434 | $5.485 | $62,715 | 219,075 (Direct) | View |
2021-10-06 Sale | 2021-10-07 9:02 pm | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 8,092 | $7.0077 | $56,706 | 993,000 (Direct) | View |
2021-09-27 Sale | 2021-09-29 1:02 pm | Equillium Inc. | EQ | Keyes Jason A CFO | 8,000 | $6.7405 | $53,924 | 120,431 (Indirect Direct) | View |
2021-07-27 Sale | 2021-07-28 11:55 am | Equillium Inc. | EQ | Keyes Jason A CFO | 5,000 | $5.717 | $28,585 | 128,431 (Indirect Direct) | View |
2021-06-04 Sale | 2021-06-09 06:03 am | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 46,424 | $7.0991 | $329,570 | 1,037,280 (Direct) | View |
2021-05-26 Sale(A) | 2021-05-28 7:03 pm | Equillium Inc. | EQ | Keyes Jason A CFO | 5,000 | $6.4967 | $32,484 | 127,896 (Indirect Direct) | View |
2021-05-26 Sale | 2021-05-28 6:20 pm | Equillium Inc. | EQ | Keyes Jason A CFO | 5,000 | $6.4967 | $32,484 | 115,720 (Indirect) | View |
2020-12-28 Sale | 2020-12-30 5:00 pm | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 25,000 | $4.5218 | $113,045 | 993,000 (Direct) | View |
2020-12-23 Sale | 2020-12-28 09:15 am | Equillium Inc. | EQ | Keyes Jason A CFO | 8,000 | $4.7392 | $37,914 | 132,896 (Indirect Direct) | View |
2020-09-28 Sale | 2020-09-30 5:00 pm | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 25,000 | $5.6158 | $140,395 | 1,018,000 (Direct) | View |
2020-07-13 Sale | 2020-07-15 5:00 pm | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 250,000 | $8.1339 | $2,033,475 | 1,043,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-03-01 Option Award | 2022-03-08 5:46 pm | N/A 2032-02-29 | Equillium Inc. | EQ | Troupin Barbara Director | 40,000 | $0 | 40,000 (Direct) | View |
2021-12-10 Option Award | 2021-12-13 10:01 am | N/A N/A | Equillium Inc. | EQ | Keyes Jason A CFO | 5,585 | $2.35 | 121,016 (Direct) | View |
2021-12-10 Option Award | 2021-12-13 09:58 am | N/A N/A | Equillium Inc. | EQ | Rothman Joel Chief Development Officer | 1,290 | $2.35 | 24,281 (Direct) | View |
2021-11-16 Exercise | 2021-11-17 3:27 pm | N/A N/A | Equillium Inc. | EQ | Zedelmayer Christine COO | 23,334 | $2.45 | 219,075 (Direct) | View |
2021-11-16 Exercise | 2021-11-17 3:27 pm | 2020-02-13 2029-02-12 | Equillium Inc. | EQ | Zedelmayer Christine COO | 23,334 | $0 | 219,075 (Direct) | View |
2021-10-06 Exercise | 2021-10-07 9:02 pm | N/A N/A | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 2,467 | $2.8 | 993,000 (Direct) | View |
2021-10-06 Exercise | 2021-10-07 9:02 pm | N/A N/A | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 5,625 | $4.75 | 993,000 (Direct) | View |
2021-10-06 Exercise | 2021-10-07 9:02 pm | 2020-12-10 2029-12-09 | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 8,092 | $0 | 993,000 (Direct) | View |
2021-06-10 Option Award | 2021-06-14 5:56 pm | N/A N/A | Equillium Inc. | EQ | Zedelmayer Christine COO | 9,032 | $2.35 | 90,509 (Direct) | View |
2021-06-10 Option Award | 2021-06-14 5:56 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A CFO | 5,535 | $2.35 | 17,711 (Direct) | View |
2021-06-10 Option Award | 2021-06-14 5:55 pm | N/A N/A | Equillium Inc. | EQ | Rothman Joel Chief Development Officer | 7,742 | $2.35 | 22,991 (Direct) | View |
2021-06-04 Exercise | 2021-06-09 06:03 am | N/A N/A | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 14,999 | $2.8 | 1,037,280 (Direct) | View |
2021-06-04 Exercise | 2021-06-09 06:03 am | N/A N/A | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 31,425 | $4.75 | 1,037,280 (Direct) | View |
2021-06-04 Exercise | 2021-06-09 06:03 am | 2021-05-19 2030-05-18 | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 46,874 | $0 | 1,037,280 (Direct) | View |
2021-05-26 Option Award | 2021-05-28 6:18 pm | N/A 2031-05-26 | Equillium Inc. | EQ | Pruzanski Mark Director | 20,770 | $0 | 20,770 (Direct) | View |
2021-05-26 Option Award | 2021-05-28 6:17 pm | N/A 2031-05-26 | Equillium Inc. | EQ | McDermott Charles Douglas Director | 20,770 | $0 | 20,770 (Direct) | View |
2021-05-26 Option Award | 2021-05-28 6:16 pm | N/A 2031-05-26 | Equillium Inc. | EQ | MANIAN BALA S Director | 20,770 | $0 | 20,770 (Direct) | View |
2021-05-26 Option Award | 2021-05-28 6:10 pm | N/A 2031-05-26 | Equillium Inc. | EQ | DEMSKI MARTHA J Director | 20,770 | $0 | 20,770 (Direct) | View |
2021-03-04 Option Award | 2021-03-05 4:30 pm | N/A 2031-03-03 | Equillium Inc. | EQ | Xu Yu (Katherine) Director | 30,000 | $0 | 30,000 (Direct) | View |
2021-02-05 Ownership | 2021-02-16 5:22 pm | N/A N/A | Equillium Inc. | EQ | Decheng Capital Global Life Sciences Fund IV L.P. Decheng Capital Management IV (Cayman) LLC Cui Xiangmin 10% Owner | 0 | $0 | 4,271,423 (Indirect) | View |
2021-02-04 Ownership | 2021-02-05 4:30 pm | N/A N/A | Equillium Inc. | EQ | Xu Yu (Katherine) Director | 0 | $0 | 0 (Direct) | View |
2021-01-26 Ownership | 2021-01-29 5:59 pm | N/A N/A | Equillium Inc. | EQ | Rothman Joel Chief Development Officer | 0 | $0 | 350,431 (Direct) | View |
2021-01-11 Option Award | 2021-01-13 4:20 pm | N/A 2031-01-10 | Equillium Inc. | EQ | Thomas Dolca Chief Medical Officer | 450,000 | $0 | 450,000 (Direct) | View |
2021-01-11 Ownership | 2021-01-13 4:19 pm | N/A N/A | Equillium Inc. | EQ | Thomas Dolca Chief Medical Officer | 0 | $0 | 0 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 5:00 pm | N/A 2031-01-03 | Equillium Inc. | EQ | Connelly Stephen Chief Scientific Officer | 100,000 | $0 | 100,000 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 5:00 pm | N/A 2031-01-03 | Equillium Inc. | EQ | BRADBURY DANIEL Chairman 10% Owner | 36,000 | $0 | 36,000 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 5:00 pm | N/A 2031-01-03 | Equillium Inc. | EQ | Zedelmayer Christine COO | 100,000 | $0 | 100,000 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 5:00 pm | N/A 2031-01-03 | Equillium Inc. | EQ | Steel Bruce D. CEO 10% Owner | 245,000 | $0 | 245,000 (Direct) | View |
2021-01-04 Option Award | 2021-01-06 5:00 pm | N/A 2031-01-03 | Equillium Inc. | EQ | Keyes Jason A CFO | 100,000 | $0 | 100,000 (Direct) | View |
2020-12-10 Other | 2020-12-11 5:00 pm | N/A N/A | Equillium Inc. | EQ | Zedelmayer Christine COO | 1,097 | $2.35 | 82,574 (Direct) | View |
2020-12-10 Other | 2020-12-11 5:00 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A CFO | 5,362 | $2.35 | 146,258 (Direct) | View |
2020-06-10 Other | 2020-06-12 4:30 pm | N/A N/A | Equillium Inc. | EQ | Zedelmayer Christine COO | 9,570 | $2.41 | 89,950 (Direct) | View |
2020-06-10 Other | 2020-06-12 4:30 pm | N/A N/A | Equillium Inc. | EQ | Keyes Jason A CFO | 5,014 | $2.41 | 140,548 (Direct) | View |
2020-05-28 Option Award | 2020-05-29 4:30 pm | 2020-05-28 2030-05-27 | Equillium Inc. | EQ | MANIAN BALA S Director | 20,634 | $0 | 20,634 (Direct) | View |